ANNOVIS BIO, INC.
Last · —$1.02-0.04 (-3.77%)live · yahoo · 0s ago
Vol 844.2K ≈ 861.1K
MA10MA20MA50
Market cap$43.53M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
Issuer
Legal nameANNOVIS BIO, INC.
HQUnited States (US)
ListingUS ANVS
ISINUS03615A1088
SectorHealthcare
IndustryBiotechnology & Medical Research
SIC2834
CurrencyUSD
Entity registrysec:0001477845
CIK0001477845
Websitewww.annovisbio.com
Employees7
AddressAnnovis Bio, Inc. 101 Lindenwood Drive 19355, Malvern +484 875 3192
Loading chart…
OpenFilings analyst
Our analyst
10-K · 2026-03-13
From latest 10-K · 2026-03-13
- Operating Cf Burn
- Cash Runway Low
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~0.8 years
- Accumulated Deficit High — Accumulated deficit / equity 971%
Press & signals
- GlobeNewswire
Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results
- Satelight
Annovis Announces Partnership with Weave Bio, AI Regulatory Platform, in
- Satelight
Annovis Provides Corporate Updates and Second Quarter 2026 Financial
Documents
FormReporting forFiledFlags
Showing 5 of 68 filings